NCT06256705View on ClinicalTrials.gov

Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

March 25, 2028

Study Completion Date

September 25, 2029

Conditions
Gastroenteropancreatic Neuroendocrine TumorRadiotherapy
Interventions
OTHER

Simultaneous 68Ga-DOTATOC PET-MRI

on month before first cycle of 177Lu-DOTATATE, after second cycle and one year after first cycle

Trial Locations (5)

44000

ACTIVE_NOT_RECRUITING

Hépato-gastro-entérologie, cancérologie digestive et assistance nutritionnelle - CHU Nantes, Nantes

RECRUITING

Médecine nucléaire - CHU Nantes, Nantes

75018

ACTIVE_NOT_RECRUITING

Service de Médecine Nucléaire, Groupe Hospitalier Bichat-Claude Bernard, Paris

92110

RECRUITING

Médecine nucléaire et Biophysique - Beaujon, Clichy

RECRUITING

Pancréatologie et Oncologie Digestive - Beaujon, Clichy

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER